BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SFPQ, PSF, 6421, ENSG00000116560, P23246 AND Treatment
7 results:

  • 1. PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2.
    Takeiwa T; Ikeda K; Suzuki T; Sato W; Iino K; Mitobe Y; Kawabata H; Horie K; Inoue S
    Sci Rep; 2022 Jun; 12(1):9495. PubMed ID: 35681031
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Likely uptake of a future a lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study.
    Broadbent R; Armitage CJ; Crosbie P; Radford J; Linton K
    BMC Pulm Med; 2022 Apr; 22(1):165. PubMed ID: 35484621
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting Epigenetic and Posttranscriptional Gene Regulation by psf Impairs Hormone Therapy-Refractory cancer Growth.
    Takayama KI; Honma T; Suzuki T; Kondoh Y; Osada H; Suzuki Y; Yoshida M; Inoue S
    Cancer Res; 2021 Jul; 81(13):3495-3508. PubMed ID: 33975881
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prediction of Overall Survival Among Female Patients With breast cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. psf Promotes ER-Positive breast cancer Progression via Posttranscriptional Regulation of
    Mitobe Y; Iino K; Takayama KI; Ikeda K; Suzuki T; Aogi K; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
    Cancer Res; 2020 Jun; 80(11):2230-2242. PubMed ID: 32213542
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Design and development of a phantom for tomosynthesis with potential for automated analysis via the cloud.
    Goodenough D; Levy J; Olafsdottir H; Olafsson I
    J Appl Clin Med Phys; 2018 May; 19(3):291-300. PubMed ID: 29508535
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Partial volume correction strategies for quantitative FDG PET in oncology.
    Hoetjes NJ; van Velden FH; Hoekstra OS; Hoekstra CJ; Krak NC; Lammertsma AA; Boellaard R
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1679-87. PubMed ID: 20422184
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.